Chimerix Patents – Insights & Stats

Chimerix has a total of 411 patents globally, out of which 163 have been granted. Of these 411 patents, 64% patents are active. United States Of America is where Chimerix has filed the maximum number of patents, followed by Europe and Japan. Parallelly, United States Of America seems to be the main focused R&D center and is also the origin country of Chimerix.

Chimerix was founded in 2000. Chimerix operates as as biopharmaceutical company. The Company develops oral antiviral therapeutics to transform patient care in multiple settings including transplant, oncology, acute care, and global health. Chimerix serves patients in the United States Of America.

Do read about some of the most popular patents of Chimerix which have been covered by us in this article and also you can find Chimerix patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Chimerix patent portfolio.

How many patents does the CEO of Chimerix have?

The CEO, Michael A. Sherman has 0 patents.

How many patents does Chimerix have?

Chimerix has a total of 411 patents globally. These patents belong to 55 unique patent families. Out of 411 patents, 264 patents are active.

How Many Patents did Chimerix File Every Year?

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantChimerix Applications FiledChimerix Patents Granted
2010261
2011391
201242
2013153
2014945
20151411
20165620
20173617
20182217
20191629
20201414
20211827
202237

How many Chimerix patents are Alive/Dead?

Worldwide Patents

How Many Patents did Chimerix File in Different Countries?

Countries in which Chimerix Filed Patents

CountryPatents
United States Of America62
Europe32
Japan30
Australia27
China24
Israel22
Canada18
Hong Kong (S.A.R.)17
Germany14
India13
Spain12
Mexico11
Singapore10
Korea (South)10
Brazil9
Denmark8
Portugal7
New Zealand7
Eurasia5
Poland5
Hungary5
Albania4
Slovenia4
Serbia4
Croatia4
Lithuania4
Montenegro2
Former Yugoslav Republic of Macedonia2
South Africa1
Philippines1
Turkey1
Taiwan1
Ireland1
Russia1
Republic of Moldova1
Macao1
Morocco1

Where are Research Centers of Chimerix Patents Located?

10 Best Chimerix Patents

WO2007130783A2 is the most popular patent in the Chimerix portfolio. It has received 80 citations so far from companies like Atea Pharmaceuticals and Fujifilm Corporation.

Below is the list of 10 most cited patents of Chimerix:

Publication NumberCitation Count
WO2007130783A280
US6599887B276
WO2008133966A174
US7749983B273
US20100297079A170
WO2010135520A160
WO2011053812A156
WO2011017253A147
US20070003608A143
WO2011011519A143

What Percentage of Chimerix US Patent Applications were Granted?

Chimerix (Excluding its subsidiaries) has filed 42 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 25 have been granted leading to a grant rate of 62.50%.

Below are the key stats of Chimerix patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Chimerix?

Law FirmTotal ApplicationsSuccess Rate
Cooley3661.76%
Adsero Ip2100.00%
Locke Lord2100.00%
Mintz Levin Boston Office10.00%
Myers Bigel10.00%

EXCLUSIVE INSIGHTS COMING SOON!

What are Chimerix key innovation segments?

What Technologies are Covered by Chimerix?

The chart below distributes patents filed by Chimerix in different countries on the basis of the technology protected in patents. It also represents the markets where Chimerix thinks it’s important to protect particular technology inventions.

R&D Focus: How has Chimerix search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Chimerix?

Related Articles

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.